Axsome Therapeutics
Price & Volume
Stats
See more52W Range | $64.11-$111.51 |
Market Cap | $5B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $338.4M |
Revenue Growth (YoY) | 81.3% |
Gross Profit (12 Mos) | $308.2M |
Diluted EPS | -$6.58 |
News
See moreYahoo Finance • 17 hours ago
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
Yahoo Finance • yesterday
Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
Yahoo Finance • 3 months ago
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yahoo Finance • 9 months ago
3 Monster Stocks in the Making You Can Buy Right Now
About
CEO | Dr. Herriot Tabuteau M.D. |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 607 |
